Show simple item record

dc.contributor.authorJefferis, J
dc.contributor.authorBerquier, I
dc.contributor.authorRice, M
dc.contributor.authorDouglas, C
dc.contributor.authorBonner, A
dc.contributor.authorPurtell, L
dc.contributor.authorHealy, H
dc.contributor.authorHepburn, K
dc.date.accessioned2021-05-14T01:58:06Z
dc.date.available2021-05-14T01:58:06Z
dc.date.issued2020
dc.identifier.issn1320-5358
dc.identifier.urihttp://hdl.handle.net/10072/404389
dc.description.abstractAims: To examine the symptom burden experienced by people with CKD attending KSC clinics and current management strategies to remediate this burden. Background: People with CKD have a high symptom burden which impacts quality of life. The multidisciplinary KSC team aims collectively to address the complexity of multifaceted, inter‐related symptoms. Methods: Retrospective analysis of 50 consecutive patients attending KSC clinics over a 2‐month period. Symptom burden was rated by patients using the validated renal palliative care outcome scale (iPOS‐renal) and EQ‐5D‐5L tools. Demographics, pathology and additional symptoms or psychosocial issues not identified with these tools (non‐iPOS) and clinician interventions were extracted from the clinical record. Analyses was performed using R. Results: Median age was 71 years, 80% male and 46% attended alone. Participants averaged 6.5 iPOS symptoms, and management strategies were implemented for an average of 3.75 iPOS symptoms and non‐iPOS issues. 32% of interventions were for psychosocial issues not identified on the iPOS. The most common symptoms identified and addressed in clinic were pain (52%), fatigue (32%), constipation (28%), low mood (26%) and pruritus (13%). The majority reported weakness/lethargy on the iPOS (78%). The median EuroQOL self‐assessment global health ranking score was 60. 32 (64%) patients were prescribed at least one new medication, of which almost half were analgesia (46%); frequently pregabalin and/or paracetamol. Targeted education around symptom self‐management was provided to 28% of patients, 56% included sleep hygiene advice, and 32% received social work interventions including referrals for increased community‐based services. Conclusions: We highlight the burden of symptoms for this older CKD population and the targeted management strategies, which span a spectrum of specialized skill‐sets and interventional approaches.
dc.languageEnglish
dc.publisherWiley
dc.publisher.urihttps://onlinelibrary.wiley.com/doi/10.1111/nep.13799
dc.relation.ispartofconferencename55th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology (ANZSN)
dc.relation.ispartofconferencetitleNephrology
dc.relation.ispartofdatefrom2020-11-28
dc.relation.ispartofdateto2020-12-02
dc.relation.ispartoflocationVirtual
dc.relation.ispartofpagefrom57
dc.relation.ispartofpageto58
dc.relation.ispartofissueS3
dc.relation.ispartofvolume25
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchcode3202
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsUrology & Nephrology
dc.titleSymptom management in people with chronic kidney disease (CKD) attending kidney supportive care (KSC) clinics
dc.typeConference output
dc.type.descriptionE3 - Conferences (Extract Paper)
dcterms.bibliographicCitationJefferis, J; Berquier, I; Rice, M; Douglas, C; Bonner, A; Purtell, L; Healy, H; Hepburn, K, Symptom management in people with chronic kidney disease (CKD) attending kidney supportive care (KSC) clinics, Nephrology, 2020, 25, pp. 57-58
dc.date.updated2021-05-14T01:56:50Z
gro.hasfulltextNo Full Text
gro.griffith.authorBonner, Ann J.
gro.griffith.authorPurtell, Louise


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record